3/6
04:52 pm
vtgn
Form 8-K Vistagen Therapeutics, For: Mar 03
Medium
Report
Form 8-K Vistagen Therapeutics, For: Mar 03
2/14
04:42 pm
vtgn
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: GREAT POINT PARTNERS LLC
2/14
04:30 pm
vtgn
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
2/14
01:02 pm
vtgn
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: STEMPOINT CAPITAL LP
Low
Report
Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: STEMPOINT CAPITAL LP
2/13
05:25 pm
vtgn
Form 10-Q Vistagen Therapeutics, For: Dec 31
Medium
Report
Form 10-Q Vistagen Therapeutics, For: Dec 31
2/13
04:46 pm
vtgn
Form 8-K Vistagen Therapeutics, For: Feb 13
Medium
Report
Form 8-K Vistagen Therapeutics, For: Feb 13
2/5
05:05 pm
vtgn
Form 8-K Vistagen Therapeutics, For: Feb 05
Medium
Report
Form 8-K Vistagen Therapeutics, For: Feb 05
1/14
05:17 pm
vtgn
Form 8-K Vistagen Therapeutics, For: Jan 14
Medium
Report
Form 8-K Vistagen Therapeutics, For: Jan 14